+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Technologies Driving Clinical Trial Management

  • ID: 4391837
  • Report
  • Region: Global
  • 63 Pages
  • Frost & Sullivan
1 of 2
Digital Technologies Disrupting the Clinical Trial Industry

Clinical trials are slow and expensive process. Over the years, especially last year, the number of drugs approved through successful clinical trials has reduced significantly. Due to several clinical trial failures, pharmaceutical companies have suffered significant revenue loss. Based on Frost and Sullivan’s research, integration of digital technologies including cloud technology, artificial intelligence, big data, predictive and prescriptive analytics, internet of medical things and mobile technology, into the clinical trial processes can improve the efficiency, fasten the clinical trials processes.

Pharmaceutical companies are embracing these digital technologies to improve patient engagement, prevent trial failures, thereby improving the profitability of drug development. This research service will showcase the emerging technologies impacting the clinical trial industry on a global scale, through a detailed strategic assessment of the industry challenges and unmet needs. Integrating of these emerging digital technologies can create further growth opportunities such as increase the chances of trial success through adaptive clinical trials, facilitate remote trials for faster and cost-effective outcomes and increase patient engagement through patient-centric trials.

Note: Product cover images may vary from those shown
2 of 2

1.0 Executive Summary
1.1 Scope of the Research
1.2 Research Methodology
1.3 Key Findings

2.0 Industry Overview
2.1 How Can the Slow, Expensive, and Risky Business of Clinical Trials Be Transformed?
2.2 In 2016, Novel Drug Approval was Less than the Average Number Approved Annually over the Past Decade
2.3 Great Revenue Loss due to Top Clinical Trial Failures in 2016
2.4 Number of Studies Registered Growing Significantly over the Years
2.5 Low-cost Healthcare and Greater Patient Diversity Attracting International Clinical Studies
2.6 Higher Number of Drug or Biologic Intervention Trials Compared to Device Clinical Trials
2.7 Trial Costs, Complexity, and Failures are the Major Challenges in the Clinical Trial Industry

3.0 Technology Snapshot and Trends
3.1 Application Segmentation: Addressing Clinical Trial Challenges through Technology Innovations
3.2 Technology Segmentation: Digital Technologies Driving Clinical Trial Management Industry
3.3 Emerging Technologies Impacting Clinical Trial Processes
3.4 Cloud Technology and Machine Learning Improving Clinical Trial Design or Protocol Development
3.4.1 Technology Companies Improving Clinical Trial Design Process
3.4.2 Collaborations and Data Sharing to Energize Clinical Trial Design
3.5 Technologies Used to Fasten Patient Recruitment Process
3.5.1 Innovative Cloud-based Online Platform for Patient Recruitment
3.5.2 Mobile Application Solution for Clinical Trial Patient Recruitment
3.5.3 Several Technology Companies Coming Forward To Solve the Problem of Patient Recruitment for Trials
3.5.4 Artificial Intelligence and Mobile Technology Improving Clinical Trial Recruitment
3.6 Digital Technologies Used to Streamline Clinical Trial Monitoring Process
3.7 Analysis and Management of Voluminous and Complex Data Simplified by Digital Technologies
3.8 Emerging Technologies for Clinical Trial Monitoring and Management
3.8.1 Some Cloud Technology Companies Helping Clinical Trial Data Capturing and Monitoring
3.8.2 Pharma Companies Integrating Cloud into its Clinical Trial Solution
3.8.3 Artificial Intelligence Revolutionizing Patient Engagement and Compliance
3.8.4 Artificial Intelligence Disrupting the Traditional Clinical Trial Management
3.8.5 Leveraging Predictive and Prescriptive Analytics to Mitigate Trial Risks
3.8.6 Mobile Applications for Clinical Trial Monitoring and Management
3.8.7 Pharma Companies Acquiring Mobile Technology Companies for Patient Engagement
3.8.8 Pharmaceutical Companies Incorporating Mobile Technology into Trials for Monitoring and Engagement
3.8.9 Convergence of Medical Device into Clinical Trials Driving Patient Monitoring
3.8.10 Pharmaceutical Companies Embracing Wearables for Trial Monitoring
3.8.11 Key Participants Providing End-to-End Solution for Entire Clinical Trial Process

4.0 Assessment of Investor Ecosystems
4.1 Venture Funding Activities Globally Boost Opportunities for Digital Technologies in Clinical Trials
4.2 Moderate Federal Funding for Supporting Clinical Trial Management

5.0 Growth Opportunities
5.1 Clinical Trial Industry Innovation Ecosystem: Key Innovators
5.2 Growth Opportunities: Adaptive Trials Increasing Chances of Trial Success
5.3 Growth Opportunities: Highly Scalable and Cost-effective Remote Clinical Trials
5.4 Growth Opportunities: Patient-centric Trials for Improved Engagement
5.5 Strategic Imperatives for the Future of the Clinical Trial Industry

6.0 Key Industry Contacts
6.1 Key Industry Contacts

Legal Disclaimer

Note: Product cover images may vary from those shown
3 of 2